STOCK TITAN

Rocket Lab Corp (RKLB) SEC Filings, Aug 13-25, 2026

RKLB NASDAQ
Rhea-AI Summary

Rocket Lab Corp (RKLB) reports that officer Frank Klein plans to sell Rocket Lab common stock under Rule 144. The planned sale relates to 81,250 shares from restricted stock vesting expected on 08/22/2026, with sales to be executed through Morgan Stanley Smith Barney LLC Executive Services on NASDAQ. A portion of the sale is intended to cover a tax obligation from the vested equity award distribution. In the past three months, Klein sold 36,860 shares on 05/28/2026 and 44,390 shares on 05/26/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Rocket Lab Corp (RKLB) is the issuer for which officer Arjun Kampani has filed a Form 144 notice of proposed sales of common stock. The notice covers 13,788 shares of common stock to be acquired through restricted stock vesting on 08/22/2026, designated as compensation from the issuer. The notice also lists prior sales over the past three months and states that the sale includes an amount necessary to cover a tax obligation arising from settlement of a vested equity award distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Rocket Lab Corp (RKLB) reports that officer Marvin Bradford Clevenger has filed a Rule 144 notice covering a proposed sale of 31,909 shares of common stock, expected on or after 08/22/2026. The shares arise from Restricted Stock Vesting received as compensation, and sales will be handled through Morgan Stanley Smith Barney LLC Executive Services. The notice states the sale includes shares needed to cover a tax obligation from the settlement of a vested equity award. It also lists prior sales of Rocket Lab common stock by Clevenger during May 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Rocket Lab Corporation (RKLB) filed Amendment No. 1 to its Form S-4 to register Rocket Lab common stock that will be issued as part of the consideration in its proposed acquisition of Iridium Communications, which will become an indirect wholly owned subsidiary and cease to be publicly traded.

Each Iridium share will be converted into $27.00 in cash plus Rocket Lab stock based on an Exchange Ratio tied to the Rocket Lab Stock Price (10‑day VWAP): 0.4000 shares if at or below $67.50, $27.00 divided by the stock price between $67.50 and $112.50, and 0.2400 shares if at or above $112.50. Iridium has 105,981,552 shares outstanding entitled to vote and will hold a virtual special meeting on September 24, 2026; approval requires a majority of outstanding shares.

The deal is expected to close in mid‑2027, subject to Iridium stockholder approval, antitrust and foreign‑investment clearances, FCC and related satellite/communications approvals, and Nasdaq listing of the new Rocket Lab shares. Rocket Lab plans to fund the cash portion using balance‑sheet cash and external financing, including a committed $3.6 billion Bridge Facility, and Iridium will terminate or refinance existing debt. The parties intend the mergers to qualify as a tax‑free reorganization under Section 368(a), but this is uncertain; if not achieved, Iridium holders could face a fully taxable transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Rocket Lab Corp (RKLB) reported that its Chief Financial Officer, Adam C. Spice, made a bona fide gift of 30,000 shares of common stock on 2026-08-17. After this gift, he holds 1,165,644 Rocket Lab common shares directly and an additional 250,000 shares indirectly through a trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.19%
Tags
insider
-
Rhea-AI Summary

Rocket Lab Corporation entered into a new Equity Distribution Agreement with Deutsche Bank Securities and Wells Fargo Securities, replacing its May 2026 program and allowing “at‑the‑market” issuances of up to $1,944,369,826 of common stock. The company plans to use any net proceeds primarily to help fund cash payments for its proposed acquisition of Iridium Communications and to reduce commitments under a committed senior secured bridge facility.

Rocket Lab also detailed complex forward sale structures, including Initially Priced Forward Transactions and Collared Forward Transactions, which may alter the timing and form of proceeds. Separately, it reported progress on the Iridium deal: expiration of the HSR antitrust waiting period on August 12, 2026, filing of a Form S-4 registration statement to register equity consideration, and joint FCC applications to transfer Iridium licenses. Rocket Lab highlighted a $3.6 billion 364‑day senior secured bridge term loan commitment and Iridium’s existing $1.775 billion term loan, and indicated plans to replace or reduce bridge commitments through a mix of permanent debt, equity (including the ATM program), and potential amendments to Iridium’s facility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
current report
Rhea-AI Summary

Rocket Lab Corporation established a new at-the-market equity program allowing sales of up to $1,944,369,826 of common stock, replacing capacity remaining under a prior $3.0 billion equity distribution agreement. Deutsche Bank Securities and Wells Fargo Securities act as sales agents and as intermediaries for complex forward and collared forward sale structures.

The company may sell shares directly or via forward purchasers that borrow and sell stock, with Rocket Lab receiving cash later upon physical or certain cash settlements. Proceeds are intended primarily to fund the cash portion of the proposed Iridium Communications acquisition, related fees, potential repayment of Iridium debt, and to reduce a $3,600.0 million bridge loan commitment; excess funds may support other growth and general corporate purposes.

The offering is not conditioned on closing the Iridium transaction, can be executed over time at prevailing Nasdaq prices, and may dilute earnings per share when shares are issued or upon settlement of forward transactions. Commissions to agents and forward sellers may be up to 2.0% of sale prices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
prospectus
-
Rhea-AI Summary

Rocket Lab Corporation reported procedural steps related to its pending acquisition of Iridium Communications Inc. Rocket Lab previously signed a Merger Agreement under which a Rocket Lab subsidiary will merge with Iridium, which is expected to become an indirect wholly owned subsidiary, followed by a second-step merger under specified conditions.

This report makes available Iridium’s historical audited and unaudited financial statements by incorporating them by reference as exhibits, and provides Rocket Lab’s unaudited pro forma condensed combined financial statements as of June 30, 2026 and for the six months ended June 30, 2026 and the year ended December 31, 2025. Rocket Lab also files the consent of Iridium’s independent auditor, KPMG LLP, so these materials can be incorporated into registration statements related to the Transaction. The closing of the Transaction remains subject to stockholder and regulatory approvals and other conditions, and extensive forward-looking statement and risk-factor language highlights uncertainties around timing, completion and anticipated benefits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
merger
-
Rhea-AI Summary

Rocket Lab Corporation describes its pending acquisition of Iridium Communications Inc. under a June 28, 2026 Merger Agreement. Iridium shareholders are to receive $27.00 in cash plus Rocket Lab stock per share, with an exchange ratio tied to Rocket Lab’s 10‑day volume‑weighted average price, generally ranging from 0.2400 to 0.4000 Rocket Lab shares per Iridium share.

The total preliminary purchase price is estimated at $7.59 billion, roughly split between $2.86 billion in cash and $2.86 billion in stock, plus assumption/payoff of Iridium debt and equity awards. To fund the cash portion, Rocket Lab obtained commitments for a $3.60 billion 364‑day senior secured bridge facility at an effective rate of about 8.0%. Pro forma financials, with Rocket Lab as accounting acquirer, show combined revenues of $878.7 million and a net loss of $154.7 million for the six months ended June 30, 2026, and revenues of $1.47 billion with a net loss of $203.0 million for 2025, reflecting higher amortization of acquired intangibles and bridge‑facility interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
current report
Rhea-AI Summary

Rocket Lab Corporation is registering shares of its common stock on Form S-4 to be issued to stockholders of Iridium Communications Inc. in a cash-and-stock acquisition. Under the Merger Agreement, each Iridium share will be converted into $27.00 in cash plus Rocket Lab stock based on a collar-style Exchange Ratio. If Rocket Lab’s 10-day volume-weighted average price is at or below $67.50, Iridium holders receive 0.4000 Rocket Lab shares; if between $67.50 and $112.50, they receive $27.00 divided by the Rocket Lab stock price; and if at or above $112.50, they receive 0.2400 shares. Iridium stock will be delisted and deregistered, and Iridium will become an indirect wholly owned subsidiary of Rocket Lab. Closing requires approval by a majority of outstanding Iridium shares, multiple regulatory clearances, Nasdaq listing of the new Rocket Lab shares and no material adverse effect for either party. Rocket Lab plans to fund the cash portion with balance sheet cash and external financing, including a committed $3.6 billion bridge facility, and currently targets completion in mid‑2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
registration

FAQ

How many Rocket Lab (RKLB) SEC filings are available on StockTitan?

StockTitan tracks 159 SEC filings for Rocket Lab (RKLB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Rocket Lab (RKLB)?

The most recent SEC filing for Rocket Lab (RKLB) was filed on August 25, 2026.